AscellaHealth

We’re excited to announce that AscellaHealth has been recognized as a 2024 #Fast500 winner by Deloitte TMT Group, ranking among the nation’s fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies for the fourth consecutive year! This year, we’re proud to be ranked #154! Congratulations to the entire AscellaHealth team and all the other winners! Read more: https://lnkd.in/g7ahg4HS #DeloitteFast500 #Innovation #Growth #Teamwork #HealthcareTech #AscellaHealth

As healthcare expenditures are projected to rise by 7% to 9% in the coming year, it’s crucial for payers to adopt innovative strategies that maximize benefit spend while reducing costs. By focusing on five key strategies, payers can manage the financial impact of specialty drugs without compromising the standard of care for their members. Learn how AscellaHealth is helping payers control rising drug costs with effective cost management strategies. Read more: https://lnkd.in/e5WCBU3A #HealthcareCosts #SpecialtyPharmacy #CostManagement #Pharmaceuticals #Payers #Innovation #AscellaHealth

We understand that successfully treating patients with complex, chronic conditions requires a dedicated team—It demands ongoing, high-touch support to help patients navigate their unique healthcare journeys. Our Patient Care Teams (PCTs) are at the heart of our patient-centered approach, offering personalized guidance every step of the way to ensure timely access to specialty therapies. Discover how AscellaHealth’s comprehensive patient care approach is driving better outcomes for both patients and pharmaceutical partners in our latest article: https://lnkd.in/egYxDMxJ #AscellaHealth #LifeSciences #PatientCareTeam #Pharma #PatientSupport #ChronicCare #RareDisease

Misconceptions vs. Reality... In Part 3 of the latest AscellaHealth Podcast Pulse episode, we explore Exclusive Distribution with Donovan Quill from AscellaHealth and Charles Gayer from BioCryst Pharmaceuticals, Inc. Pharmaceuticals. Join us as we dig into the common myths and misconceptions surrounding exclusive distribution models and explain how sole-source distribution can foster deeper partnerships, streamline processes, and increase stability for all life sciences stakeholders, while enhancing cross-functional collaboration and optimizing outcomes across the board. Listen here:?https://lnkd.in/eCV-jP9N #AscellaHealth #Podcast #ExclusiveDistribution #HealthcareStrategy #RareDisease #SpecialtyPharmacy #LifeSciences #Innovation #Spotify?

Misconceptions vs. Reality... In Part 3 of the latest AscellaHealth Podcast Pulse episode, we explore Exclusive Distribution with Donovan Quill from AscellaHealth and @Charlie Gayer from BioCryst Pharmaceuticals, Inc. Join us as we dig into the common myths and misconceptions surrounding exclusive distribution models and explain how sole-source distribution can foster deeper partnerships, streamline processes, and increase stability for all life sciences stakeholders, while enhancing cross-functional collaboration and optimizing outcomes across the board.? Listen here:??https://lnkd.in/eCV-jP9N #AscellaHealth #Podcast #ExclusiveDistribution #HealthcareStrategy #RareDisease #SpecialtyPharmacy #LifeSciences #Innovation #Spotify??

ICYMI: Exciting news from AscellaHealth! We’ve recently released the latest edition of our Specialty & Rare Pipeline Digest?— your essential digital resource for the latest updates on specialty and rare disease drugs, cell and gene therapies (CGTs) and biosimilars. This complimentary quarterly publication provides timely insights to help stakeholders and decision-makers navigate the evolving specialty drug market. Download your copy here: https://lnkd.in/epMupw4w #AscellaHealth #SpecialtyDrugs #RareDiseases #CGTs #Biosimilars

Happy Veteran’s Day to all who have served, continue to serve, and to their loved ones who support them. Your invaluable service inspires us all. Thank you, Veterans! #HappyVeteransDay #VeteransDay2024 #thankyouveterans #HonoringOurVets #grateful?

AscellaHealth recognizes National Family Caregivers Month by honoring the millions of caregivers across the nation who provide essential support for patients with rare diseases and complex conditions. With over 53 million family members offering care, and 20 million becoming new caregivers each year, we’re committed to supporting them year-round. Caregiving for individuals with rare conditions can be overwhelming, often leading to emotional and financial strain as caregivers juggle demanding responsibilities. Our specialty pharmacists and care coordinators are dedicated to assisting patients and caregivers with coordinated support that addresses the unique challenges of managing rare diseases. We extend our heartfelt gratitude to caregivers for their unwavering support, not just this month, but throughout the year. Thank you for all that you do! #rarediseases #patientfirst #specialtypharmacy #caregiversupport #nationalcaregiversmonth #raredisease #thankyou #caregivers

It was a pleasure to host Charles Gayer from BioCryst Pharmaceuticals, Inc. on the AscellaHealth Podcast Pulse and have the opportunity to tap into his extensive expertise within the biopharmaceutical industry. In Part 2 of our Exclusive Distribution episode, he sat alongside AscellaHealth’s Donovan Quill to dive deep into the unique benefits of collaborating with a sole-source, exclusive distribution partner like AscellaHealth. Tune in below to hear their insightful discussion! Listen here: https://lnkd.in/eUjmthKG #AscellaHealth #Podcast #ExclusiveDistribution #HealthcareStrategy #RareDisease #SpecialtyPharmacy #LifeSciences #Innovation #Spotify ?

Exciting news! We’re thrilled to introduce our latest white paper: "Transforming Global Healthcare: Establishing a Collaborative Framework for Specialty Pharmaceutical Stakeholders in the Treatment of Complex, Chronic Diseases." This evidence-based resource delves into the critical challenges life sciences companies, payers, healthcare providers, and patients currently face within the global specialty healthcare landscape. It offers actionable strategies for improving treatment access, clinical outcomes and cost management to help stakeholders strengthen and streamline the commercialization of specialty pharmaceuticals. #AscellaHealth #SpecialtyPharmacy #Payers #Pharma #LifeSciences #Healthcare #WhitePaper Download the full white paper here: https://lnkd.in/eb-CHn3G